Activation of the STING adaptor attenuates experimental autoimmune encephalitis

Journal of Immunology

Volumn 192, Issue 12, 2014, Pages 5571-5578

  Lemos, Henrique ^a   Huang, Lei ^a   Chandler, Phillip R ^a   Mohamed, Eslam ^a   Souza, Guilherme R ^a,b   Li, Lingqian ^a   Pacholczyk, Gabriela ^a   Barber, Glen N ^c   Hayakawa, Yoshihiro ^d   Munn, David H ^a   Mellor, Andrew L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF MIAMI   (United States)

^d AICHI INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; CYCLIC DIGUANYLATE MONOPHOSPHATE; DNA NANOPARTICLE; GUANOSINE PHOSPHATE; INDOLEAMINE 2,3 DIOXYGENASE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NANOPARTICLE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EFFECTOR CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE; GENE ACTIVATION; IFN ALPHABETA RECEPTOR GENE; IMMUNIZATION; INNATE IMMUNITY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; STIMULATOR OF IFN GENE; TREATMENT RESPONSE;

ANIMALS; DNA; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERONS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES, REGULATORY;

EID: 84902170924     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303258     Document Type: Article

References (44)

1. Gall, A., P. Treuting, K. B. Elkon, Y. M. Loo, M. Gale, Jr., G. N. Barber, and D. B. Stetson. 2012. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36:120-131.
2. Ahn, J., D. Gutman, S. Saijo, and G. N. Barber. 2012. STING manifests self DNAdependent inflammatory disease. Proc. Natl. Acad. Sci. USA 109:19386-19391.
3. Simmons, S. B., E. R. Pierson, S. Y. Lee, and J. M. Goverman. 2013. Modeling the heterogeneity of multiple sclerosis in animals. Trends Immunol. 34:410-422.
4. McGaha, T. L., L. Huang, H. Lemos, R. Metz, M. Mautino, G. C. Prendergast, and A. L. Mellor. 2012. Amino acid catabolism: a pivotal regulator of innate and adaptive immunity. Immunol. Rev. 249:135-157.
5. Grohmann, U., C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M. L. Belladonna, R. Bianchi, M. C. Fioretti, and P. Puccetti. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3:1097-1101.
6. Mellor, A. L., B. Baban, P. Chandler, B. Marshall, K. Jhaver, A. Hansen, P. A. Koni, M. Iwashima, and D. H. Munn. 2003. Cutting edge: induced indoleamine 2, 3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171:1652-1655.
7. Lan, Z., W. Ge, J. Arp, J. Jiang, W. Liu, D. Gordon, D. Healey, M. De Benedette, C. Nicolette, B. Garcia, and H. Wang. 2010. Induction of kidney allograft tolerance by soluble CD83 associated with prevalence of tolerogenic dendritic cells and indoleamine 2, 3-dioxygenase. Transplantation 90:1286-1293.
8. Baban, B., P. R. Chandler, M. D. Sharma, J. Pihkala, P. A. Koni, D. H. Munn, and A. L. Mellor. 2009. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J. Immunol. 183:2475-2483.
9. Fallarino, F., U. Grohmann, K. W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, M. L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4:1206-1212.
10. Fallarino, F., C. Volpi, T. Zelante, C. Vacca, M. Calvitti, M. C. Fioretti, P. Puccetti, L. Romani, and U. Grohmann. 2009. IDO mediates TLR9-driven protection from experimental autoimmune diabetes. J. Immunol. 183:6303-6312.
11. Guillonneau, C., J. D. Mintern, F. X. Hubert, A. C. Hurt, G. S. Besra, S. Porcelli, I. G. Barr, P. C. Doherty, D. I. Godfrey, and S. J. Turner. 2009. Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc. Natl. Acad. Sci. USA 106:3330-3335.
12. Mellor, A. L., B. Baban, P. R. Chandler, A. Manlapat, D. J. Kahler, and D. H. Munn. 2005. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2, 3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling. J. Immunol. 175:5601-5605.
13. Fallarino, F., and P. Puccetti. 2006. Toll-like receptor 9-mediated induction of the immunosuppressive pathway of tryptophan catabolism. Eur. J. Immunol. 36:8-11.
14. Boasso, A. 2011. Wounding the immune system with its own blade: HIV-induced tryptophan catabolism and pathogenesis. Curr. Med. Chem. 18:2247-2256.
15. Banchereau, J., and V. Pascual. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25:383-392.
16. Baban, B., A. M. Hansen, P. R. Chandler, A. Manlapat, A. Bingaman, D. J. Kahler, D. H. Munn, and A. L. Mellor. 2005. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Int. Immunol. 17:909-919.
17. Huang, L., H. P. Lemos, L. Li, M. Li, P. R. Chandler, B. Baban, T. L. McGaha, B. Ravishankar, J. R. Lee, D. H. Munn, and A. L. Mellor. 2012. Engineering DNA nanoparticles as immunomodulatory reagents that activate regulatory T cells. J. Immunol. 188:4913-4920.
18. Huang, L., L. Li, H. Lemos, P. R. Chandler, G. Pacholczyk, B. Baban, G. N. Barber, Y. Hayakawa, T. L. McGaha, B. Ravishankar, et al. 2013. Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses. J. Immunol. 191:3509-3513.
19. Ishikawa, H., Z. Ma, and G. N. Barber. 2009. STING regulates intracellular DNAmediated, type I interferon-dependent innate immunity. Nature 461:788-792.
20. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De Los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17:211-220.
21. Ravishankar, B., H. Liu, R. Shinde, P. Chandler, B. Baban, M. Tanaka, D. H. Munn, A. L. Mellor, M. C. Karlsson, and T. L. McGaha. 2012. Tolerance to apoptotic cells is regulated by indoleamine 2, 3-dioxygenase. Proc. Natl. Acad. Sci. USA 109:3909-3914.
22. Das Sarma, J., B. Ciric, R. Marek, S. Sadhukhan, M. L. Caruso, J. Shafagh, D. C. Fitzgerald, K. S. Shindler, and A. Rostami. 2009. Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis. J. Neuroinflammation 6:14.
23. Hou, D. Y., A. J. Muller, M. D. Sharma, J. Du Hadaway, T. Banerjee, M. Johnson, A. L. Mellor, G. C. Prendergast, and D. H. Munn. 2007. Inhibition of indoleamine 2, 3-dioxygenase in dendritic cells by stereoisomers of 1-methyltryptophan correlates with antitumor responses. Cancer Res. 67:792-801.
24. Hoshi, M., K. Saito, A. Hara, A. Taguchi, H. Ohtaki, R. Tanaka, H. Fujigaki, Y. Osawa, M. Takemura, H. Matsunami, et al. 2010. The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouse. J. Immunol. 185:3305-3312.
25. Rothhammer, V., S. Heink, F. Petermann, R. Srivastava, M. C. Claussen, B. Hemmer, and T. Korn. 2011. Th17 lymphocytes traffic to the central nervous system independently of a4 integrin expression during EAE. J. Exp. Med. 208:2465-2476.
26. Sriram, S. 2011. Role of glial cells in innate immunity and their role in CNS demyelination. J. Neuroimmunol. 239:13-20.
27. Hamilton, N. H., J. L. Banyer, A. J. Hapel, S. Mahalingam, A. J. Ramsay, I. A. Ramshaw, and S. A. Thomson. 2002. IFN-γ regulates murine interferoninducible T cell a chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE). Scand. J. Immunol. 55:171-177.
28. Sakurai, K., J. P. Zou, J. R. Tschetter, J. M. Ward, and G. M. Shearer. 2002. Effect of indoleamine 2, 3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 129:186-196.
29. Burdette, D. L., K. M. Monroe, K. Sotelo-Troha, J. S. Iwig, B. Eckert, M. Hyodo, Y. Hayakawa, and R. E. Vance. 2011. STING is a direct innate immune sensor of cyclic di-GMP. Nature 478:515-518.
30. Kwidzinski, E., and I. Bechmann. 2007. IDO expression in the brain: a doubleedged sword. J. Mol. Med. 85:1351-1359.
31. Kim, H., L. Chen, G. Lim, B. Sung, S. Wang, M. F. McCabe, G. Rusanescu, L. Yang, Y. Tian, and J. Mao. 2012. Brain indoleamine 2, 3-dioxygenase contributes to the comorbidity of pain and depression. J. Clin. Invest. 122:2940-2954.
32. Munn, D. H., and A. L. Mellor. 2013. Indoleamine 2, 3 dioxygenase and metabolic control of immune responses. Trends Immunol. 34:137-143.
33. Anderson, G., M. Maes, and M. Berk. 2012. Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization. Adv. Protein Chem. Struct. Biol. 88:27-48.
34. Farias, A. S., G. S. Spagnol, P. Bordeaux-Rego, C. O. Oliveira, A. G. Fontana, R. F. De Paula, M. P. Santos, F. Pradella, A. S. Moraes, E. C. Oliveira, et al. 2013. Vitamin D3 induces IDO+ tolerogenic DCs and enhances Treg, reducing the severity of EAE. CNS Neurosci. Ther. 19:269-277.
35. Rodrigo-Garzón, M., P. Berraondo, L. Ochoa, J. J. Zulueta, and G. González-Aseguinolaza. 2010. Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis. Cancer Gene Ther. 17:20-27.
36. Munn, D. H. 2012. Blocking IDO activity to enhance anti-tumor immunity. Front. Biosci. (Elite Ed.) 4:734-745.
37. Yuan, B., L. Zhao, F. Fu, Y. Liu, C. Lin, X. Wu, H. Shen, and Z. Yang. 2014. A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis. Mol. Immunol. 57:93-99.
38. Zugates, G. T., W. Peng, A. Zumbuehl, S. Jhunjhunwala, Y. H. Huang, R. Langer, J. A. Sawicki, and D. G. Anderson. 2007. Rapid optimization of gene delivery by parallel end-modification of poly (b-amino ester) s. Mol. Ther. 15:1306-1312.
39. Sun, L., J. Wu, F. Du, X. Chen, and Z. J. Chen. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-791.
40. Wu, J., L. Sun, X. Chen, F. Du, H. Shi, C. Chen, and Z. J. Chen. 2013. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339:826-830.
41. Schoggins, J. W., D. A. Macduff, N. Imanaka, M. D. Gainey, B. Shrestha, J. L. Eitson, K. B. Mar, R. B. Richardson, A. V. Ratushny, V. Litvak, et al. 2014. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505:691-695.
42. Gray, P. M., G. Forrest, T. Wisniewski, G. Porter, D. C. Freed, J. A. De Martino, D. M. Zaller, Z. Guo, J. Leone, T. M. Fu, and K. A. Vora. 2012. Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities. Cell. Immunol. 278:113-119.
43. Conlon, J., D. L. Burdette, S. Sharma, N. Bhat, M. Thompson, Z. Jiang, V. A. Rathinam, B. Monks, T. Jin, T. S. Xiao, et al. 2013. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5, 6-dimethylxanthenone-4-acetic acid. J. Immunol. 190:5216-5225.
44. Yi, G., V. P. Brendel, C. Shu, P. Li, S. Palanathan, and C. Cheng Kao. 2013. Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides. PLoS ONE 8:e77846